Lithuanian Laboratory Implementation Guide
0.0.1 - ci-build
Lithuanian Laboratory Implementation Guide, published by Lithuanian Medical Library. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7LT/ig-lt-lab/ and changes regularly. See the Directory of published versions
This page lists the StructureDefinition profiles defined in the Lithuanian Laboratory Implementation Guide. Use them to ensure consistent representation of laboratory results, pathology reports, and specimen data across systems.
| Profile | Purpose |
|---|---|
| Cholesterol Total | Total cholesterol concentration in serum or plasma. |
| Cholesterol Non-HDL | Non-HDL cholesterol (total minus HDL), a cardiovascular risk marker. |
| Cholesterol HDL | HDL cholesterol concentration in serum or plasma. |
| Cholesterol LDL | LDL cholesterol, measured directly or by calculation. |
| Triglycerides | Triglyceride concentration for lipid metabolism assessment. |
| Lipidogram | Lipid panel grouping Total Cholesterol, LDL-C, HDL-C, and Triglycerides. |
| Glucose in Venous Blood | Glucose concentration in venous blood. |
| Profile | Purpose |
|---|---|
| HbA1c | Glycated hemoglobin (HbA1c) test for diabetes monitoring. |
| Profile | Purpose |
|---|---|
| ACR | Urine albumin-to-creatinine ratio for kidney function assessment. |
| Creatinine Test | Serum or plasma creatinine concentration. |
| eGFR | Estimated glomerular filtration rate (CKD-EPI formula). |
| Profile | Purpose |
|---|---|
| Pathology Order | ServiceRequest for pathology laboratory orders. |
| Pathology Composition | Synoptic pathology document with LOINC-coded sections (Pre-Analytic, Macro, Micro, Synthesis). |
| Pathology Report | DiagnosticReport for pathology laboratory results. |
| Prostate Cancer Condition | Prostate cancer diagnosis with TNM staging and morphology. |
| Biopsy Procedure | Biopsy procedure for histopathological examination. |
| HER2 Receptor Status | HER2 receptor expression status (IHC/molecular). |
| HER2 FISH/CISH/SISH | HER2 gene amplification molecular test with HER2 average, CEP17 average, ratio, and classification. |
| Estrogen Receptor Status | IHC estrogen receptor (ER) status with expression level and percentage. |
| Progesterone Receptor Status | IHC progesterone receptor (PR) status with expression level and percentage. |
| Ki-67 Proliferation Index | Ki-67 proliferation index as percentage of positive tumor cells. |
| Profile | Purpose |
|---|---|
| Specimen | Laboratory specimen with identifier, collection, and processing details. |
| Specimen: Tissue Block | Paraffin-embedded tissue block derived from a parent specimen. |
| Substance: Specimen Additive | Additive substance used in specimen collection or processing. |
| Specimen Adequacy | Observation assessing whether a specimen is adequate for evaluation. |
| Specimen Measurement | Physical measurements of a specimen (dimensions, weight, lymph node count). |
| Tumor Measurement | Tumor measurement observations. |
| Tumor Observable | Tumor observable component observations. |
| Extension | Purpose |
|---|---|
| specimen-received-by | Practitioner who received the specimen at the laboratory. |
For terminology used by these profiles, see Terminology; for sample instances, see Examples.